Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Trial in Progress: An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with and without G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Nina Caculitan, Josephine M. Cardarelli, Jack Khouri, Hyung C Suh, Muthalagu Ramanathan, Ann Woolfrey

Blood (2023) 142 (Supplement 1): 7082.

https://doi.org/10.1182/blood-2023-187191

Published: 2023

Journal Articles

Combination of Propranolol and a Novel CXCR4 Antagonist Burixafor (GPC-100) for Enhanced Hematopoietic Cell Mobilization

Devki D. Sukhtankar, Thomas Cayton, Piotr Zalicki, Junhee Choi, Seonggyeong Mun, Yoonjung Jo, Sujeong Kim, Ji Yeong Lee, Mi-Na Kim, Ashley Chin, Christian Ramos, Won-Ki Huh, Sohui Kim, Nina Caculitan, Jae-Yeon Jeong, Josephine M. Cardarelli

Blood (2023) 142 (Supplement 1): 3428.

https://doi.org/10.1182/blood-2023-182226

Published: 2023

Journal Articles

GPC-100 Is a Novel CXCR4 Inhibitor That Leads to Improved in Vitro Potency and In Vivo Efficacy in Stem Cell Mobilization When Combined with a Beta-Blocker

Juan Jose Fung, Valerie Chiou, Jaemin Lee, Yongdae Jang, Junhee Choi, Piotr Zalicki, Thomas Cayton, Ashley Chin, Niña Caculitan, SoHui Kim, Jiyeong Lee, Devki Sukhtankar, Eunhee Kim, Josephine Cardarelli

Blood (2022) 140 (Supplement 1): 4489–4490.

https://doi.org/10.1182/blood-2022-160248

Published: 2022